Drug Approval | October 05, 2022
Casper Pharma receives EIR from USFDA for its PAI
The inspection concluded with no observation (FDA-483) issued.
The inspection concluded with no observation (FDA-483) issued.
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
The inspection of the facility was conducted from August 16-19, 2022.
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
Funds raised will be used to develop technology and foster healthcare partnerships
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.
Subscribe To Our Newsletter & Stay Updated
